Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy

por Islam, Rasa, Pupovac, Aleta, Evtimov, Vera, Boyd, Nicholas, Shu, Runzhe, Boyd, Richard, Trounson, Alan
Publicado 2021

‘Off-the-Shelf’ Immunotherapy: Manufacture of CD8(+) T Cells Derived from Hematopoietic Stem Cells

por Boyd, Nicholas, Cartledge, Kellie, Cao, Huimin, Evtimov, Vera, Pupovac, Aleta, Trounson, Alan, Boyd, Richard
Publicado 2021

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies

por To, Van, Evtimov, Vera J., Jenkin, Graham, Pupovac, Aleta, Trounson, Alan O., Boyd, Richard L.
Publicado 2022

Micro-hydrogel injectables that deliver effective CAR-T immunotherapy against 3D solid tumor spheroids

por Suraiya, Anisha B., Evtimov, Vera J., Truong, Vinh X., Boyd, Richard L., Forsythe, John S., Boyd, Nicholas R.
Publicado 2022

Engineered CAR-T cells targeting TAG-72 and CD47 in ovarian cancer

por Shu, Runzhe, Evtimov, Vera J., Hammett, Maree V., Nguyen, Nhu-Y N., Zhuang, Junli, Hudson, Peter J., Howard, Maureen C., Pupovac, Aleta, Trounson, Alan O., Boyd, Richard L.
Publicado 2021

Engineering T cell receptor fusion proteins using nonviral CRISPR/Cas9 genome editing for cancer immunotherapy

por Shu, Runzhe, Hammett, Maree, Evtimov, Vera, Pupovac, Aleta, Nguyen, Nhu‐Y, Islam, Rasa, Zhuang, Junli, Lee, Seyeong, Kang, Tae‐hun, Lee, Kyujun, Nisbet, Ian, Hudson, Peter, Lee, Jae Young, Boyd, Richard, Trounson, Alan
Publicado 2023